TBPH Theravance Biopharma Inc

USD 9.72 +0.29 ( +3.08%)
Icon

Theravance Biopharma Inc (TBPH) Stock Analysis and Price Targets

COMMON STOCK | Biotechnology | NSD
stockTargetAdvisor

Buy

Average Analyst
Rating
stockTargetAdvisor

Buy

Top Analyst
Rating
stockTargetAdvisor

Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

Strong Buy

Average User
Rating

USD 9.72

+0.29 (+3.08%)

USD 0.51B

0.12M

USD 12.50(+28.60%)

USD 15.00 (+54.32%)

Icon

TBPH

Theravance Biopharma Inc (USD)
COMMON STOCK | NSD
USD 9.72
+0.29 ( +3.08%)

Theravance Biopharma Inc (TBPH) Stock Forecast

Show ratings and price targets of :
USD 12.50
(+28.60%)

Based on the Theravance Biopharma Inc stock forecast from 3 analysts, the average analyst target price for Theravance Biopharma Inc is USD 12.50 over the next 12 months. Theravance Biopharma Inc’s average analyst rating is Buy . Stock Target Advisor’s own stock analysis of Theravance Biopharma Inc is Bearish, which is based on 2 positive signals and 6 negative signals. At the last closing, Theravance Biopharma Inc’s stock price was USD 9.72. Theravance Biopharma Inc’s stock price has changed by +0.93% over the past week, +4.40% over the past month and +9.83% over the last year.

Analyst Ratings

Target Price Action Rating Action Analyst Rating Price Date

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...